We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NA:NASDAQNano Labs Ltd Analysis

Data as of 2026-05-25 - not real-time

$2.48

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Nano Labs Ltd trades at a strikingly low PE of 2.48, far below the semiconductor industry average of 39.5, suggesting a potentially deep discount. However, the company’s fundamentals are weak: gross margin is negative (-26.5%), operating margin is severely negative (-194.9%), and both operating and free cash flow are large negatives, indicating cash‑burn. The balance sheet is strained with a debt‑to‑equity ratio of 31.8 and total debt of $235 M dwarfing its $57.5 M market cap. Technicals reinforce a bearish outlook – the 20‑day SMA (2.16) sits well below the 50‑day SMA (2.59) and the 200‑day SMA (3.76), and price is nearer the support level ($1.58) than the resistance ($2.84). RSI at 52 is neutral, while MACD shows a modest bullish histogram but the overall trend direction is flagged as bearish. Volatility is extreme at 154% over the past 30 days, and beta (≈1.05) points to market‑aligned risk. Recent news of a Memorandum of Understanding with Sigma Corporation to explore AI infrastructure could provide a catalyst, yet the partnership is non‑binding and its impact remains speculative. Liquidity is thin, with decreasing volume and an average 10‑day volume well below daily trading levels. Given the combination of deep discount pricing, deteriorating cash flows, high leverage, and elevated market risk, the stock presents a high‑risk, value‑oriented proposition. Investors should weigh the potential upside from the AI collaboration against the substantial financial and operational headwinds.
Overall, the current environment favors caution, with any upside hinging on successful execution of strategic initiatives and a turnaround in cash generation.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Bearish SMA alignment (20‑day below 50‑day below 200‑day)
  • High 30‑day volatility (154%)
  • Negative operating cash flow and mounting debt

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Potential upside from AI infrastructure MOU
  • Extremely low valuation multiples (PE 2.48)
  • Continued cash‑burn and leverage concerns

Long Term

> 3 years
Neutral
Model confidence: 4/10

Key Factors

  • Structural industry risk and regulatory headwinds in China
  • Uncertain path to profitability despite cheap price
  • Possibility of strategic turnaround if AI partnership matures

Key Metrics & Analysis

Financial Health

Revenue Growth18.10%
Profit Margin501.60%
P/E Ratio2.5
ROE25.87%
ROA-5.37%
Debt/Equity31.79
P/B Ratio0.5
Op. Cash Flow$-108268896
Free Cash Flow$-176946048
Industry P/E39.5

Technical Analysis

TrendBearish
RSI52.2
Support$1.58
Resistance$2.84
MA 20$2.16
MA 50$2.59
MA 200$3.76
MACDBullish
VolumeDecreasing
Fear & Greed Index91.8

Valuation

GradeUndervalued
TypeValue

Risk Assessment

Beta1.05
Volatility154.10%
Sector RiskHigh
Reg. RiskHigh
Geo RiskHigh
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.